 |
Lacnotuzumab |
|---|---|
| Trade Name | |
| Orphan Indication | Pigmented villonodular synovitis, including giant cell tumor of the tendon sheath |
| USA Market Approval | USA |
| USA Designation Date | 2014-08-19 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corp;One Health Plaza;East Hanover, New Jersey, 07936 |
